Review appropriate treatment regimens for patients with metastatic melanoma.
This educational activity is intended for clinicians practicing in the areas of hematology-oncology, dermatology, pathology and lab medicine.
The goal of this activity is to build healthcare professionals' confidence in strategies for the individualized treatment of the patient with malignant melanoma and to ensure that updated guidelines and other emerging best practices are applied across a variety of clinical presentations.
Approximate Time to Complete: 1 hour
Course Available Beginning: Nov. 22, 2016
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
- Devise a treatment strategy for a patient with newly diagnosed metastatic melanoma based on clinical presentation, medical history, tumor burden and patient preferences
- Select the most appropriate treatment regimen for a patient with metastatic melanoma whose disease has progressed on first-line therapy
- Counsel patients about common adverse effects associated with selected therapy